Should older adults be screened for dementia? It is important to screen for evidence of dementia!

J. Wesson Ashford, Soo Borson, Ruth O'Hara, Paul Dash, Lori Frank, Philippe Robert, William R. Shankle, Mary C. Tierney, Henry Brodaty, Frederick A. Schmitt, Helena C. Kraemer, Herman Buschke, Howard Fillit

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Multiple arguments for considering routine dementia screening have been presented. Furthermore, dementia diagnoses are widely unrecognized. As a result, persons with dementia are missing important clinical care and treatment interventions. By distinction, the problems of defining, diagnosing, and treating mild cognitive impairment (MCI) are not yet resolved, and MCI is not ready for a screening recommendation. Dementia screening approaches, including cognitive testing and functional assessment, must be evaluated on their scientific merits, including sensitivity and specificity for recognizing affected individuals in at-risk populations. Screening tests must be "cost-worthy", with the benefits of true-positive test results justifying the costs of testing and resolving false-positive cases, with due consideration for proper diagnostic evaluation and potential harms. With the tremendous number of new cases projected in the near future and the expected emergence of beneficial therapies, considerably more research is needed to develop more efficient screening systems.

Original languageEnglish (US)
Pages (from-to)75-80
Number of pages6
JournalAlzheimer's and Dementia
Volume3
Issue number2
DOIs
StatePublished - Apr 2007

Fingerprint

Dementia
Costs and Cost Analysis
Sensitivity and Specificity
Research
Cognitive Dysfunction
Therapeutics

Keywords

  • Alzheimer's disease
  • Case-finding
  • Dementia
  • Diagnosis
  • Mild cognitive impairment
  • Screening

ASJC Scopus subject areas

  • Health Policy
  • Epidemiology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience
  • Developmental Neuroscience
  • Clinical Neurology

Cite this

Ashford, J. W., Borson, S., O'Hara, R., Dash, P., Frank, L., Robert, P., ... Fillit, H. (2007). Should older adults be screened for dementia? It is important to screen for evidence of dementia! Alzheimer's and Dementia, 3(2), 75-80. https://doi.org/10.1016/j.jalz.2007.03.005

Should older adults be screened for dementia? It is important to screen for evidence of dementia! / Ashford, J. Wesson; Borson, Soo; O'Hara, Ruth; Dash, Paul; Frank, Lori; Robert, Philippe; Shankle, William R.; Tierney, Mary C.; Brodaty, Henry; Schmitt, Frederick A.; Kraemer, Helena C.; Buschke, Herman; Fillit, Howard.

In: Alzheimer's and Dementia, Vol. 3, No. 2, 04.2007, p. 75-80.

Research output: Contribution to journalArticle

Ashford, JW, Borson, S, O'Hara, R, Dash, P, Frank, L, Robert, P, Shankle, WR, Tierney, MC, Brodaty, H, Schmitt, FA, Kraemer, HC, Buschke, H & Fillit, H 2007, 'Should older adults be screened for dementia? It is important to screen for evidence of dementia!', Alzheimer's and Dementia, vol. 3, no. 2, pp. 75-80. https://doi.org/10.1016/j.jalz.2007.03.005
Ashford, J. Wesson ; Borson, Soo ; O'Hara, Ruth ; Dash, Paul ; Frank, Lori ; Robert, Philippe ; Shankle, William R. ; Tierney, Mary C. ; Brodaty, Henry ; Schmitt, Frederick A. ; Kraemer, Helena C. ; Buschke, Herman ; Fillit, Howard. / Should older adults be screened for dementia? It is important to screen for evidence of dementia!. In: Alzheimer's and Dementia. 2007 ; Vol. 3, No. 2. pp. 75-80.
@article{62c162fd98c240999c9cd356063fd7b6,
title = "Should older adults be screened for dementia? It is important to screen for evidence of dementia!",
abstract = "Multiple arguments for considering routine dementia screening have been presented. Furthermore, dementia diagnoses are widely unrecognized. As a result, persons with dementia are missing important clinical care and treatment interventions. By distinction, the problems of defining, diagnosing, and treating mild cognitive impairment (MCI) are not yet resolved, and MCI is not ready for a screening recommendation. Dementia screening approaches, including cognitive testing and functional assessment, must be evaluated on their scientific merits, including sensitivity and specificity for recognizing affected individuals in at-risk populations. Screening tests must be {"}cost-worthy{"}, with the benefits of true-positive test results justifying the costs of testing and resolving false-positive cases, with due consideration for proper diagnostic evaluation and potential harms. With the tremendous number of new cases projected in the near future and the expected emergence of beneficial therapies, considerably more research is needed to develop more efficient screening systems.",
keywords = "Alzheimer's disease, Case-finding, Dementia, Diagnosis, Mild cognitive impairment, Screening",
author = "Ashford, {J. Wesson} and Soo Borson and Ruth O'Hara and Paul Dash and Lori Frank and Philippe Robert and Shankle, {William R.} and Tierney, {Mary C.} and Henry Brodaty and Schmitt, {Frederick A.} and Kraemer, {Helena C.} and Herman Buschke and Howard Fillit",
year = "2007",
month = "4",
doi = "10.1016/j.jalz.2007.03.005",
language = "English (US)",
volume = "3",
pages = "75--80",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Should older adults be screened for dementia? It is important to screen for evidence of dementia!

AU - Ashford, J. Wesson

AU - Borson, Soo

AU - O'Hara, Ruth

AU - Dash, Paul

AU - Frank, Lori

AU - Robert, Philippe

AU - Shankle, William R.

AU - Tierney, Mary C.

AU - Brodaty, Henry

AU - Schmitt, Frederick A.

AU - Kraemer, Helena C.

AU - Buschke, Herman

AU - Fillit, Howard

PY - 2007/4

Y1 - 2007/4

N2 - Multiple arguments for considering routine dementia screening have been presented. Furthermore, dementia diagnoses are widely unrecognized. As a result, persons with dementia are missing important clinical care and treatment interventions. By distinction, the problems of defining, diagnosing, and treating mild cognitive impairment (MCI) are not yet resolved, and MCI is not ready for a screening recommendation. Dementia screening approaches, including cognitive testing and functional assessment, must be evaluated on their scientific merits, including sensitivity and specificity for recognizing affected individuals in at-risk populations. Screening tests must be "cost-worthy", with the benefits of true-positive test results justifying the costs of testing and resolving false-positive cases, with due consideration for proper diagnostic evaluation and potential harms. With the tremendous number of new cases projected in the near future and the expected emergence of beneficial therapies, considerably more research is needed to develop more efficient screening systems.

AB - Multiple arguments for considering routine dementia screening have been presented. Furthermore, dementia diagnoses are widely unrecognized. As a result, persons with dementia are missing important clinical care and treatment interventions. By distinction, the problems of defining, diagnosing, and treating mild cognitive impairment (MCI) are not yet resolved, and MCI is not ready for a screening recommendation. Dementia screening approaches, including cognitive testing and functional assessment, must be evaluated on their scientific merits, including sensitivity and specificity for recognizing affected individuals in at-risk populations. Screening tests must be "cost-worthy", with the benefits of true-positive test results justifying the costs of testing and resolving false-positive cases, with due consideration for proper diagnostic evaluation and potential harms. With the tremendous number of new cases projected in the near future and the expected emergence of beneficial therapies, considerably more research is needed to develop more efficient screening systems.

KW - Alzheimer's disease

KW - Case-finding

KW - Dementia

KW - Diagnosis

KW - Mild cognitive impairment

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=34247174922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247174922&partnerID=8YFLogxK

U2 - 10.1016/j.jalz.2007.03.005

DO - 10.1016/j.jalz.2007.03.005

M3 - Article

VL - 3

SP - 75

EP - 80

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

SN - 1552-5260

IS - 2

ER -